These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 8931907
1. The menopause and the cardiovascular system. Beale CM, Collins P. Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):483-513. PubMed ID: 8931907 [Abstract] [Full Text] [Related]
2. The menopause and HRT. Hormone replacement therapy, cardiovascular and cerebrovascular disease. Teede HJ. Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):73-90. PubMed ID: 12763513 [Abstract] [Full Text] [Related]
3. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy. Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C. J Endocrinol Invest; 2005 Mar; 28(10 Suppl):80-4. PubMed ID: 16550729 [Abstract] [Full Text] [Related]
4. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Norman RJ, Flight IH, Rees MC. Cochrane Database Syst Rev; 2000 Mar; (2):CD001018. PubMed ID: 10796730 [Abstract] [Full Text] [Related]
5. Hormones and cardiovascular health in women. ESHRE Capri Workshop Group. Hum Reprod Update; 2006 Mar; 12(5):483-97. PubMed ID: 16807276 [Abstract] [Full Text] [Related]
6. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women. Seed M, Sands RH, McLaren M, Kirk G, Darko D. Fam Pract; 2000 Dec; 17(6):497-507. PubMed ID: 11120722 [Abstract] [Full Text] [Related]
7. Comparative cardiovascular effects of different progestins in menopause. Rosano GM, Fini M. Int J Fertil Womens Med; 2001 Dec; 46(5):248-56. PubMed ID: 11720197 [Abstract] [Full Text] [Related]
8. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease. Whittington R, Faulds D. Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266 [Abstract] [Full Text] [Related]
9. Cardiovascular disease in women and noncontraceptive use of hormones: a feminist analysis. MacPherson KI. ANS Adv Nurs Sci; 1992 Jun; 14(4):34-49. PubMed ID: 1605587 [Abstract] [Full Text] [Related]
10. The menopause: benefits and risks of estrogen-progestogen replacement therapy. Gambrell RD. Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116 [Abstract] [Full Text] [Related]
11. [Historical perspective of hormone replacement therapy]. Chanson P. Rev Prat; 2005 Feb 28; 55(4):369-75. PubMed ID: 15828614 [Abstract] [Full Text] [Related]
12. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women. McCrohon JA, Adams MR, McCredie RJ, Robinson J, Pike A, Abbey M, Keech AC, Celermajer DS. Clin Endocrinol (Oxf); 1996 Oct 28; 45(4):435-41. PubMed ID: 8959082 [Abstract] [Full Text] [Related]
13. [Risks, benefits and costs of hormone replacement therapy in menopause]. Gaspard U. Rev Med Liege; 1998 May 28; 53(5):298-304. PubMed ID: 9689887 [Abstract] [Full Text] [Related]
14. [Cardiovascular risk and hormone replacement therapy in menopause]. Plu-Bureau G. Therapie; 1999 May 28; 54(3):375-80. PubMed ID: 10500454 [Abstract] [Full Text] [Related]
15. Vascular effects of estrogenic menopausal hormone therapy. Reslan OM, Khalil RA. Rev Recent Clin Trials; 2012 Feb 28; 7(1):47-70. PubMed ID: 21864249 [Abstract] [Full Text] [Related]
16. [Pharmacology of estrogens and progestogens and cardiovascular risk]. Boissel JP, Cornu C. Therapie; 1999 Feb 28; 54(3):387-92. PubMed ID: 10500456 [Abstract] [Full Text] [Related]